To what extent is the association between obesity and colorectal cancer risk mediated by systemic inflammation?

Fatemeh Safizadeh , Marko Mandic , Michael Hoffmeister , Hermann Brenner

Cancer Communications ›› 2025, Vol. 45 ›› Issue (4) : 442 -455.

PDF
Cancer Communications ›› 2025, Vol. 45 ›› Issue (4) : 442 -455. DOI: 10.1002/cac2.12659
LETTER TO THE JOURNAL

To what extent is the association between obesity and colorectal cancer risk mediated by systemic inflammation?

Author information +
History +
PDF

Cite this article

Download citation ▾
Fatemeh Safizadeh, Marko Mandic, Michael Hoffmeister, Hermann Brenner. To what extent is the association between obesity and colorectal cancer risk mediated by systemic inflammation?. Cancer Communications, 2025, 45(4): 442-455 DOI:10.1002/cac2.12659

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Body fatness and weight gain and the risk of cancer. Available from: https://www.wcrf.org/wp-content/uploads/2021/01/Body-fatness-and-weight-gain_0.pdf

[2]

Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015; 15(8): 484-98.

[3]

Murphy N, Jenab M, Gunter MJ. Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. Nat Rev Gastroenterol Hepatol. 2018; 15(11): 659-70.

[4]

Gilmore LA, Olaechea S, Gilmore BW, Gannavarapu BS, Alvarez CM, Ahn C, et al. A preponderance of gastrointestinal cancer patients transition into cachexia syndrome. J Cachexia Sarcopenia Muscle. 2022; 13(6): 2920-31.

[5]

Wang QL, Babic A, Rosenthal MH, Lee AA, Zhang Y, Zhang X, et al. Cancer Diagnoses After Recent Weight Loss. Jama. 2024; 331(4): 318-28.

[6]

Mandic M, Safizadeh F, Niedermaier T, Hoffmeister M, Brenner H. Association of Overweight, Obesity, and Recent Weight Loss With Colorectal Cancer Risk. JAMA Netw Open. 2023; 6(4): e239556.

[7]

Safizadeh F, Mandic M, Pulte D, Niedermaier T, Hoffmeister M, Brenner H. The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort. Br J Cancer. 2023; 129(5): 829-837.

[8]

Song M, Wu K, Ogino S, Fuchs CS, Giovannucci EL, Chan AT. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men. Br J Cancer. 2013; 108(9): 1891-8.

[9]

Bodén S, Myte R, Harbs J, Sundkvist A, Zingmark C, Löfgren Burström A, et al. C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2020; 29(7): 1482-91.

[10]

Guirguis-Blake JM, Evans CV, Perdue LA, Bean SI, Senger CA. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Jama. 2022; 327(16): 1585-97.

RIGHTS & PERMISSIONS

2025 The Author(s). Cancer Communications published by John Wiley & Sons Australia, Ltd on behalf of Sun Yat-sen University Cancer Center.

AI Summary AI Mindmap
PDF

20

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/